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We explore the interplay between amino acid se-
quence, thermodynamic stability, and functional
fitness in the M2 proton channel of influenza A virus.
Electrophysiological measurements show that drug-
resistant mutations have minimal effects on M2’s
specific activity, and suggest that resistance is
achieved by altering a binding site within the pore
rather than a less direct allosteric mechanism. In par-
allel, we measure the effects of these mutations on
the free energy of assembling the homotetrameric
transmembrane pore from monomeric helices in mi-
celles and bilayers. Although there is no simple corre-
lation between the evolutionary fitness of themutants
and their stability, all variants formedmore stable tet-
ramers in bilayers, and the least-fit mutants showed
the smallest increase in stability upon moving from
a micelle to a bilayer environment. We speculate
that the folding landscape of a micelle is rougher
than that of a bilayer, and more accommodating of
conformational variations in nonoptimized mutants.
INTRODUCTION
Our understanding of the determinants of membrane protein
structure is at a relatively primitive level when compared to that
of water-soluble proteins. One reason for this disparity is the
relative paucity of membrane proteins in the crystallographic da-
tabase, but a second reason relates to the lack of methodical
studies of how systematic changes in sequence affect the ther-
modynamics of folding, particularly in bilayers. Although consid-
erable progress has been made on this front for bproteins (Tamm
et al., 2004), the a-helical class of membrane proteins has been
more refractory to analysis. Whereas encouraging results have
been obtained in micelles, the interpretation of these studies is
complicated by the difficulty in characterizing the amount ofStructure 1residual structure in the unfolded state (Bowie, 2004). One excep-
tion to this problem is the case of glycophorin A; because the
native state of this transmembrane (TM) helix is dimeric, the un-
folded state can be defined as a monomeric helix (Fisher et al.,
1999) that is devoid of any interactions with its partner. The ther-
modynamics of dimerization of glycophorin A and other related
peptides (Fleming et al., 2004, 1997; Fleming and Engelman,
2001) are well correlated with their association in bacterial mem-
branes (Russ and Engelman, 1999, 2000; Senes et al., 2000).
However, extensive thermodynamic measurements in bilayers
as compared to micelles have not been accomplished. Clearly,
direct measurement in both systems on the same peptide system
would be a great contribution to the current knowledge.
Here we examine the effects of mutations on the function and
thermodynamics of folding in phospholipid bilayers of a series of
mutations of the AM2 proton channel from the influenza A virus,
some of which were previously characterized by equilibrium an-
alytical ultracentrifugation (EAUC) in micelles. AM2 is a 97 amino
acid protein from the influenza A virus that homotetramerizes to
form a proton channel. This protein is one of the smallest ion
channels known, yet it exhibits properties of selectivity (Chizh-
makov et al., 1996; Lin and Schroeder, 2001; Mould et al.,
2000; Shimbo et al., 1996; Venkataraman et al., 2005), activation
(Chizhmakov et al., 2003; Wang et al., 1995), and gating (Okada
et al., 2001; Tang et al., 2002). AM2 has a single transmembrane
helix of 25 residues (M2TM; Figure 1) that retains the ability to
tetramerize, conduct protons, and bind the anti-influenza drug
amantadine (Salom et al., 2000). The thermodynamic analysis
of this ion channel is simplified because folding involves the
homo-oligomerization of a single membrane-spanning helix.
However, due to AM2’s functional complexity, our findings
may be extended to more complex membrane proteins.
A significant motivation of this study has been to determine
how different mutations allow the protein to escape inhibition
by amantadine, and how overall stability relates to this process.
Of the several amantadine-insensitive mutations observed in
the last two decades, S31N is particularly fit (Abed et al., 2005;
Holsinger et al., 1994). This mutation renders the virus highly
resistant to amantadine inhibition, and the incidence of clinical6, 1067–1076, July 2008 ª2008 Elsevier Ltd All rights reserved 1067
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Stability and Function of a Viral Proton Channelisolates bearing this mutation has jumped from a few percent
to approximately 97% in recent years (Deyde et al., 2007),
prompting the Centers for Disease Control to recommend dis-
continuing the use of this drug (Bright et al., 2005, 2006). This mu-
tation is found in 99% of H3N2 viruses, which dominated the
2005–2006 flu season. It also occurs with very high frequency
in H5N1, and is being found at increasing rates in H1N1 viruses,
where it also occurs even in the absence of amantadine usage
(Hayden, 2006). Recent strains of the virus bearing this mutation
are now called the N lineage of the virus (Simonsen et al., 2007). In
the crystal structure (Stouffer et al., 2008), solution NMR structure
(Schnell and Chou, 2008), solid-state NMR structural model (Hu
et al., 2007), and computational models of M2 (Chen et al.,
2007; Nishimura et al., 2002; Pinto et al., 1997), this mutation
lies near the conduction pore of the virus and was widely believed
to escape inhibition by altering the shape of the amantadine-
binding site observed in the crystal structure of the protein. How-
ever, a recent NMR investigation of the protein in the presence of
40 mM rimantadine, a related drug, concluded that the drug in-
stead binds ‘‘allosteric’’ sites on the outside of the closed state
of the channel, and that amantadine-resistant mutations strongly
stabilize the open conformation (Schnell and Chou, 2008). To ad-
dress this question, we report here measurements of the specific
activity of drug-resistant mutants expressed in oocytes, but fail to
find evidence for strong stabilization of an open conformation.
Previously, we used the EAUC method to determine the effect
of numerous sequence variations on the stability of the proton
channel in detergent micelles (Howard et al., 2002; Stouffer
et al., 2005). The pore-lining residues and residues at the helix-
helix interface were mutated to alanine and phenylalanine
(Howard et al., 2002; Stouffer et al., 2005). We found that almost
all of the mutations favored tetramerization over the wild-type and
only mutations involving the polar His37 residue destabilized the
tetramer. These findings constrast with the extreme conservation
of the amino acid sequence found throughout AM2 proton-
channel strains, suggesting that the sequence requirements for
stability of the tetramer are quite modest whereas the require-
ments for function are quite stringent. Thus, the channel protein’s
sequence does not appear to evolve toward thermodynamic sta-
bility, but for function—specifically, to allow formation and inter-
change of a number of functional conformations, each required
for gating and transmission of protons. Here we extend this anal-
ysis to determine the effect of a subset of these mutations on the
channel stability in a bilayer environment. We also examine how
these changes in sequence influence proton-channel activities.
To determine the free energy of association in bilayers, we
employed the method of equilibrium thiol-disulfide interchange to
examine some of the most and least stabilizing mutations as deter-
Figure 1. M2 Transmembrane-Spanning Peptides
The M2TM22–46 peptides from the Udorn strain of influenza A virus are used in
EAUC studies and the M219–46 peptides are used for thiol-disulfide exchange
experiments. The positions of single-site mutations and their identities are
highlighted in cyan. The bottom sequence is from the Weybridge strain of
influenza A virus containing the L38F mutation (variations in magenta).1068 Structure 16, 1067–1076, July 2008 ª2008 Elsevier Ltd All righmined in detergent micelles. Additionally, the reversal voltage and
specific activity of some AM2 mutants were measured in oocytes.
We found thatall of thevariants formmorestable tetramers inphos-
pholipid bilayers versus micelles. Moreover, there are functionally
interesting differences in the degree of stabilization of the mutants
inmicellesversusbilayers; sequencevariants fromhighlyfit andvir-
ulent forms of the virus favor tetramerization in bilayers over muta-
tions that have not been observed in field of isolates of the virus.
RESULTS
Variants of M2TM
This study focuses on natural and unnatural mutations that have
interesting effects on the thermodynamic stability and function
of the channel in micelles. These variants include mutations
whose stabilities vary by 2.3 kcal/mol tetramer (Table 1), some
of which also perturb the binding of the anti-influenza drug aman-
tadine to the proton pore. In our previous study (Howard et al.,
2002; Stouffer et al., 2005), we found H37A to be the only mutation
that strongly destabilizes the tetramer. It was also chosen for this
study because of the importance of histidine in channel function.
The four histidine residues that line the channel pore are involved
in proton selectivity, which is eliminated by the H37A mutation
(Czabotar et al., 2004; Gandhi et al., 1999; Venkataraman et al.,
2005), and form transient interhelical interactions with Trp41 in
the gating process (Okada et al., 2001; Wu and Voth, 2005).
We also studied I33A, L26F, and L38F, which were the three
most stabilizing sequence variants previously studied (Stouffer
et al., 2005). Each of these has a different phenotype of interest
to this work. I33A was chosen as an amantadine-resistant mu-
tant that, to our knowledge, has not been observed in naturally
occurring strains of influenza A virus. L26F was investigated as
an amantadine-resistant mutant that is not widely distributed in
the absence of selective pressure from the presence of amanta-
dine (Abed et al., 2005; Kitahori et al., 2006; Suzuki et al., 2003);
viruses bearing this mutation have smaller plaque sizes than
normal (Abed et al., 2005). Finally, L38F is a natural mutation
that occurs in the Weybridge strain (Figure 1) and other strains
of influenza A virus. Although L38F shows a decrease in its ability
to bind amantadine (Stouffer et al., 2005), the Weybridge strain is
vulnerable to the drug (Wang et al., 1993).
The peptides studied here, designated M2TM19–46, are slightly
longer than the peptides previously studied, M2TM22–46, by
EAUC (Figure 1). The peptides have been extended to Cys19,
which forms an interchain disulfide (Holsinger and Lamb, 1991)
in native M2, and enables measurement of stability through
thiol-disulfide interchange in the present study. In the reduced
free-thiol form, the additional residues do not significantly affect
the free energy of tetramerization of the peptides in micelles us-
ing analytical ultracentrifugation (Cristian et al., 2003a). Mutants
whose free energy of tetramerization were not previously
reported have now been determined by the same method, and
their stabilities are reported in Table 1. For the functional assays,
full-length M2 protein mutants were used.
Measurement of Stability Using Equilibrium
Thiol-Disulfide Interchange in Phospholipid Bilayers
The method of thiol-disulfide interchange in lipid bilayers
has been successfully developed to measure the tetramerts reserved
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Stability and Function of a Viral Proton ChannelTable 1. Free Energies of Dissociation (DGtet) for Wild-Type and M2TM Mutant Peptides
Micelles Vesicles
DGtet(kcal/mol) DDGtet(kcal/mol) DGtet(kcal/mol) DDGtet(kcal/mol)
WT 8.3 ± 0.1a 11.2 ± 0.12
L26F 10.6 ± 0.1a 2.3 ± 0.2 12.7 ± 0.27 1.5 ± 0.3
S31N 8.7 ± 0.1 0.4 ± 0.2 12.4 ± 0.27 1.2 ± 0.3
I33A 10.1 ± 0.1a 1.8 ± 0.2 12.2 ± 0.59 1.0 ± 0.2
H37A 6.9 ± 0.1 1.4 ± 0.2 10.2 ± 0.16 1.0 ± 0.2
L38F 10.4 ± 0.1a 2.1 ± 0.2 14.1 ± 0.16 2.9 ± 0.6
The change of energy upon mutation is also expressed relative to wild-type as DDGtet. Curve fits for the M2TM S31N and H37A peptides are located in
Figure S1 available online. Experimental error for DGtet in EAUC (micelles) was found in repeated measurements of WT to be ± 0.12 (Stouffer et al.,
2006). With the thiol-disulfide interchange method used for vesicles, errors in absolute DGtet, estimated by fixing K2 to its upper and lower limits
(determined from the WT fitting) and refitting each mutant data set, were between 0.5 and 0.8 kcal/mol. However, because we were interested inDDGtet
values for the different environments,DGtet values for the vesicle experiments were calculated from the least-squares fitting errors in K1 for each mutant
and WT. We then used the root-mean-square error for each mutant with WT to calculate the resulting errors for theDDGtets. This was done because K2,
whose value showed strong correlation with K1, was assumed to be the same as WT for all mutants.
a Previously reported in Stouffer et al. (2005).dissociation constant of M2TM19–46 (Cristian et al., 2003a,
2003b). The method involves measuring the equilibrium between
the reduced and disulfide-bonded form of the protein under re-
versible redox conditions using a glutathione redox buffer at
equilibrium. If the experiments are conducted under conditions
in which the protein is primarily monomeric in the reduced form
but tetrameric when oxidized, one can analyze the peptide con-
centration dependence of the equilibrium to obtain the dissocia-
tion constant for tetramerization (Figure 2).
This method requires a substantial monomer population in
equilibrium with the tetrameric form of the protein at experimen-
tally accessible peptide-to-lipid ratios. Previously, we found that
this could be accomplished by incorporating the peptide into
short-chain lipid bilayers formed from DLPC (1,2-dilauroyl-
sn-glycero-3-phosphocholine), in which the tetrameric confor-
mation is less stable than in longer-chain lipid bilayers such as
DMPC (1,2-dimyristoyl-sn-glycero-3-phosphocholine) or POPC
(1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine) (Cristian
et al., 2003b). Although a thicker bilayer is more biologically
relevant, the tetramer was essentially fully formed in long-chain
lipids. Also, the head group and hydrocarbon chain length of
DLPC are similar to that of the dodecyl phosphocholine (DPC)
detergent used in the analytical centrifugation experiments,
allowing a more direct comparison between the two studies.
Once the system achieves equilibrium, analytical HPLC is
used to quantitate the amount of monomer- and disulfide-
bonded dimer (as a result of tetramerization) at equilibrium for
Figure 2. The Thermodynamic Equilibrium between Disulfide Cou-
pling and Tetramer Formation
This scheme includes all thermodynamically significant species as previously
reported (Cristian et al., 2003b). The oxidation states of monomer (Mon) and
tetramer (Tet) are denoted in the subscripts as SH for reduced and SS for
oxidized. Oxidized and reduced glutathione is represented as GSSG and
GSH, respectively. The first K2 value is given a coefficient of three, because
there are three potential disulfide partners in the reduced tetramer.Structure 16various peptide-to-lipid ratios. The resultant dimer population
is an attribute of the affinity and cooperativity of M2TM tetrame-
rization (Cristian et al., 2003a). The dissociation constants and
equilibria are fit to the experimental data as previously shown
(Figure 3; Cristian et al., 2003b). The free energy of tetramer dis-
sociation (Ktet) is then calculated by DG = RT lnKtet. To obtain
the best estimate of Ktet, the experiments were conducted at
a glutathione oxidized to a reduced molar ratio of 1:2. This ratio
allowed measurement of the least stable to the most stable var-
iants under a single experimental condition.
Sequence Variants Are More Stable in Lipids
versus Micelles, Yet the Effects of Mutations
on Stability Are Correlated
As expected, DGtet of dissociation for the wild-type and each of
the sequence variants is more favorable in DLPC vesicles than in
the DPC micelles used in the EAUC experiments (Table 1). The
tetramers are more stable in bilayers than in micelles by up to
3.7 kcal/mol tetramer, depending on the sequence variant. Con-
sidering that the contribution to the overall stability of the addi-
tional N-terminal residues is only 0.5 kcal/mol tetramer (Cristian
et al., 2003a), these stabilizing effects are quite significant.
L26F and S31N Mutant Ion-Channel Proteins Retain
Activity and Proton Selectivity, Whereas Amantadine
Sensitivity Is Lost
To gain an understanding of the function of these point muta-
tions, we compared the properties of the mutants in the full-
length proteins in Xenopus oocytes. The effects of mutating
H37 to Gly and other small residues have already been very ex-
tensively studied; these mutations lead to channels with highly
compromised selectivity (Venkataraman et al., 2005). The effects
of mutating L38 to Phe has also been thoroughly investigated,
and this mutation has little effect when made in the sequence
studied here (Betakova et al., 2005; Chizhmakov et al., 2003;
Wang et al., 1993). Thus, we focused on a comparison of WT,
L26F, and S31N, as these mutations eliminate amantadine
binding and thermodynamically stabilize the formation of tetra-
mers in the M2TM peptides (Stouffer et al., 2005). As depicted
in Figure 4, both L26F and S31N mutant channels displayed a, 1067–1076, July 2008 ª2008 Elsevier Ltd All rights reserved 1069
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wild-type ion channel. To allow the detection of weak amanta-
dine sensitivity expected for the mutants, measurements were
conducted at a high (100 mM) drug concentration, which is
approximately 100-fold greater than the IC50 for the WT protein.
As expected, the wild-type protein was essentially completely in-
hibited by treatment for 2–3 min with 100 mM amantadine, and
this inhibition did not reverse over a 5 min period following re-
moval of the drug (Figure 4A). By contrast, the ion-channel activ-
ity of the S31N mutant was inhibited by only 30%, and this small
inhibition was immediately reversed after the removal of the drug
(Figure 4C). The L26F mutant ion channel was also reversibly in-
hibited by amantadine (Figure 4B), although the inhibition (47%)
was somewhat higher than for S31N (p < 0.001). Thus, S31N is
more resistant to inhibition by amantadine than L26F.
Given that these mutants are approximately 100-fold more
resistant to amantadine than the WT, the allosteric model pre-
dicts (Schnell and Chou, 2008) a similarly large change in their
conductance characteristics associated with a parallel increase
in the stability of the open state. Furthermore, the effect should
be more marked for S31N than L26F, because S31N is more
resistant to amantadine. We therefore measured the surface ex-
pression, specific activity, and proton selectivity for these AM2
variants (Figure 5A). The amount of protein expressed on the sur-
face of the cell was approximately the same for the S31N, L26F,
and WT protein, indicating that the mutations did not affect the
ability of the protein to be biosynthetically incorporated into the
plasma membrane. The specific activity is defined as the current
at pH 5.5 divided by the amount of protein expressed at the
surface of the oocyte for each cell studied. In practice, it is
computed from the slope of the current at pH 5.5 versus the sur-
Figure 3. M2TM19–46 Tetramer Formation in Lipid Vesicles
The dissociation constant and equilibria for disulfide coupling and tetramer
formation is fit to the percent dimer formation for each respective peptide to
the DLPC lipid molar ratio (C) for wild-type M2TM19–46 and the five sequence
variants.1070 Structure 16, 1067–1076, July 2008 ª2008 Elsevier Ltd All rightface expression of M2 obtained in 10–20 experiments. In con-
trast to the allosteric model (Schnell and Chou, 2008), the spe-
cific activity of S31N is very similar to wild-type, showing only
a 1.4-fold increase in specific activity. In further contradiction
to the allosteric model, the specific activity of L26F is 1.35-fold
greater than the specific activity of S31N, despite the fact that
S31N is more resistant to amantadine than L26F.
We also examined the ion selectivity of these two channel pro-
teins by measuring the reversal voltage (Vrev) in normal Na
+
Barth’s solution (Figure 5B). The reversal potentials of all the mu-
tant ion channels were the same within experimental error, indi-
cating that the L26F and S31N mutant M2 channels retain very
high proton selectivity.
DISCUSSION
Structural Basis for Modulation of Stability
The M2 proton channel is a pH-gated channel that is activated at
low pH. Very recently, structures of the tetrameric transmem-
brane region of the protein were solved at low and neutral pH
by X-ray crystallography (Stouffer et al., 2008), and at high pH
by NMR structure (Schnell and Chou, 2008). The structures are
broadly similar, but show conformational changes consistent
with the pH-dependent opening of the channel at low pH. Given
that our measurements were conducted at high pH, it is most
appropriate to consider their effects in the context of the high-
pH form of the channel, and the positions of the changes have
been shown on the transmembrane domain in Figures 6A and
6B. Both the NMR and crystal structures confirm that all of the
mutations studied in this work lie along the helix-helix interface
of the tetramer, with the exception of His37, which projects
toward the center of the channel. His37 engages in numerous
stabilizing interactions with nearby Trp residues, explaining the
destabilizing nature of mutations to this residue. The effects of
the other mutations are also broadly consistent with the struc-
ture. For example, the mutation of Leu26 or Leu38 to Phe can
easily be accommodated at the helix-helix interface, where the
larger Phe side chain can pack favorably against the neighboring
helix. Interestingly, I33A occurs in a region that is rich in small
residues, which are particularly favorable for helix-helix interac-
tions in membranes (Senes et al., 2000, 2004); mutation of
Ile33 to Ala might facilitate and extend the packing of a patch
of small residues that includes Ser31 and Gly34 on one helix
and Ala30 of a neighboring helix. Finally, the mutation S31N
can be accommodated by placing the Asn side chain within
the aqueous pore (Stouffer et al., 2008).
Thermodynamic Stability in Bilayers versus Micelles
All five homotetrameric peptides have a higher stability in bila-
yers than in micelles (Table 1), which can be related to intrinsic
differences between the two hydrophobic environments. In this
study, we used short-chained lipid vesicles to facilitate the
experiment, and to allow comparison with the measurements
in DPC micelles. However, the protein is even more stable in
membranes with longer chain lengths and/or in the presence
of cholesterol (Cristian et al., 2003b). Thus, chain lengths that
are more similar to physiological lipids would show much greater
increases in stability and have an even greater impact on the
conformational specificity of the tetramer.s reserved
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in the two environments (Figure 7); mutations that are stabilizing
in micelles remain stabilizing in bilayers, and the destabilizing
mutation was also destabilizing in both environments. The prob-
ability that all five mutations would have the same effect in the
two environments is approximately 0.55 = 0.03, indicating that
this finding is significant. Regression analysis of the tetrameriza-
tion free energies (Figure 8) gave a near unitary slope and a good
correlation (R = 0.86) between the stability of the mutants in the
two environments. In general, the mutations are several kcal/mol
more stable in bilayers versus micelles over the experimental
range examined. There are, however, deviations of individual
points from the regression line that are beyond the error bars,
suggesting that there could be differential effects of the environ-
ment on each mutant.
In micelles, the detergent molecules decorate themselves
around a transmembrane protein, which allows for considerable
structural flexibility. On the other hand, bilayers align the charged
and the hydrophobic sectors of integral membrane proteins in
a more geometrically restricted manner. Thus, folding within
Figure 4. pH Activation and Amantadine Sensitivity of L26F, S31N,
and WT AM2 Channels
Oocytes expressing WT AM2 protein or either mutant protein displayed robust
inward current (downward reflection) 48–72 hr after mRNA injection when oo-
cytes were bathed in Barth’s solution (pH 5.5). Amantadine sensitivity of these
AM2 variants was evaluated by bathing the oocytes in Barth’s solution (pH 5.5)
that contained 100 mM amantadine when the oocyte displayed maximal inward
current. A representative trace is shown for each AM2 variant.
(A) WT AM2. Amantadine inhibits 95.2% ± 1.5% (n = 5) of the inward current,
and this inhibition is not reversible.
(B) L26F AM2. Amantadine inhibits 46.8% ± 0.7% (n = 4) of the inward current,
and this inhibition is readily reversible.
(C) S31N AM2. Amantadine inhibits 30.7% ± 1.8% (n = 4) of the inward current,
and this inhibition is also highly reversible. Inhibition is greater for L26F than for
S31N mutant protein (p < 0.001).Structure 1a micelle might occur on a more rugged energetic landscape,
with many more potential minima than encountered in the
more restricted conformational space available in a bilayer. In
this scenario, mutations could have a net stabilizing effect in a mi-
celle environment—not by lowering the energy level of the native
conformations, but rather by stabilizing one or more nonnative
states that are accessible only in micelles. Also, these mutations
might upset a delicate energetic balance by stabilizing only one
of multiple conformations required for function. One might ex-
pect, then, that naturally occurring, highly fit mutations should
be highly stabilizing to the full ensemble of native structures,
whereas the unnatural or less-fit mutations might induce nonna-
tive conformations in the more malleable environment of a
micelle than in a bilayer. The data do suggest this could be the
case; S31N and L38F lie above the trend line in Figure 8, whereas
the less-fit L26F and I33A (not observed in natural viruses) muta-
tions lie below the line. The selective increase in stability of S31N
over WT is also consistent with previous studies showing that
Asn is able to stabilize TM helical bundles (Choma et al., 2000;
Gratkowski et al., 2001; Lear et al., 2003). These observations
suggest a possible explanation for previous observations con-
cerning the effects of mutations in membrane proteins (Bowie,
2001): it is often surprisingly easy to discover mutations that
increase stability without showing major effects on a membrane
protein’s function measured in vitro. We speculate that such
mutations affect the energetic landscape, allowing misfolding
or other events that might be apparent only after extended times
in vivo.
Implications for the Structure of the Amantadine-M2
Complex and the Development of Drug Resistance
It is interesting to consider our results in light of the recent dra-
matic increase in the resistance of viruses to amantadine and
rimantadine. In the crystal structure of the amantadine-M2TM
complex, the drug appears to be bound in the pore surrounded
by residues that are mutated in amantadine-resistant viruses
(Stouffer et al., 2008). Mutating Ser31 to Asn is expected to
decrease the radius and/or increase the polarity of the pore,
thereby interfering with binding. The mutation L26F also de-
creases amantadine sensitivity, although not to the same extent
as S31N. Its proximity to the crystallographically defined aman-
tadine-binding site suggests that it might alter the geometry of
the pore sufficiently to decrease the affinity for amantadine.
This possibility is consistent with its location near the N termi-
nus of the helix, where the bundle is least restrained and hence
might undergo conformational changes in response to even
subtle mutations, particularly when the changes are repeated
at each monomer of the subunit.
Although our results are consistent with the crystallographic
structure of the amantadine-M2 complex, they are less consis-
tent with the surface location of four drug-binding sites observed
in the NMR structure (Schnell and Chou, 2008). Other facts that
are difficult to reconcile with the NMR model include: (1) the drug
is known to bind in a stoichiometry of one drug/tetramer with
a Hill coefficient of 1.0 (Czabotar et al., 2004; Wang et al.,
1993); (2) amantadine-resistant mutations cluster in a region sur-
rounding the N-terminal region of the pore, rather than at the pro-
posed surface sites near the C terminus of the channel (Stouffer
et al., 2008); (3) mutations to each of the residues predicted to6, 1067–1076, July 2008 ª2008 Elsevier Ltd All rights reserved 1071
Structure
Stability and Function of a Viral Proton ChannelFigure 5. Specific Activity and Reversal
Voltage of L26F, S31N, andWTAM2Channel
Expressed in Oocytes
(A) For each AM2 variant, at least four oocytes
expressing the M2 protein and three uninjected
oocytes were measured. The current for each un-
injected cell and for each cell expressing a given
protein was plotted against the immunofluores-
cence signal intensity for that cell and a straight
line was fitted to the data. The slope of this plot
was taken as the relative specific activity of the
protein. The resulting slopes were as follows:
AM2 WT, slope = 1.164 ± 0.059; L26F, slope =
2.183 ± 0.143; and S31N, slope = 1.624 ± 0.116
(F = 29.9, DFn = 35, p < 0.001).
(B) Membrane conductance measurements were made at pH 5.5; after membrane current reached the maximal value, a 100 mV ramp of voltage from40 to 60 mV
was applied. For each cell expressing a given M2 channel, the reversal voltage was plotted against the steady inward current for that cell and a straight line was
fitted to the plot. The y intercept of this plot was taken as the reversal voltage (Vrev) of the protein. The Vrev values were as follows: AM2 WT, Vrev = 41.0 ± 2.4 mV;
L26F, Vrev = 49.4 ± 3.8 mV; and S31N, Vrev = 40.2 ± 4.5 mV (F = 0.47, DFn = 25, p = 0.63).comprise the NMR-defined drug-binding sites (residues 40–45)
had little effect on the ability of amantadine to block the channel
(Pinto et al., 1997; Tang et al., 2002); (4) amantadine and riman-
tadine bind to the channel very slowly and dissociate even more
slowly, which is inconsistent with the rapid kinetics expected for
a surface binding site; (5) the NMR structure contains an unfilled
site in the pore of the channel that is surrounded by residues
important for amantadine binding and that could sterically
accommodate the drug (Figure 6C); and (6) the residues lining
the site in the pore where the drug was expected to bind show
no nuclear Overhauser effects (NOEs) with water molecules, de-
spite the fact the channel is 7 A˚ wide at this point, and hence
would be expected to be filled with water (unless the drug was
actually there but not detected due to motional averaging).
These contradictions were rationalized by suggesting that the
drug inhibits the channel allosterically by binding to the surface
site, which predicts that mutations strongly stabilize the open
state of the channel. However, the electrophysiological studies
of L26F and S31N were not consistent with this expectation. In-1072 Structure 16, 1067–1076, July 2008 ª2008 Elsevier Ltd All righstead, they lend support to a large body of data indicating that
biologically relevant mutants escape amantadine inhibition by
alterations to the amantadine-binding site in the pore. Thus,
the binding sites observed on the outside of the channel in the
NMR structure appear to be secondary sites, possibly related
to the amine-binding sites observed under some conditions in
vesicle assays (Lin et al., 1997). The observation of a secondary
site might be a result of the experimental conditions used in the
NMR structure determination (Schnell and Chou, 2008); the drug
was present at 40 mM concentration, the detergent at 300 mM,
and the tetramer at 0.2 mM (0.75 mM in the monomer). Given that
rimantidine partitions almost entirely into the micelle, it consti-
tuted 13% of the micellar components (Schnell and Chou,
2008). A protein with a cross-sectional area similar to the M2
tetramer has been shown to bind at least 90 molecules of dihex-
anoylphosphatidylcholine (the same detergent as in the M2
work) (Fernandez et al., 2002; Hilty et al., 2004), indicating that
there were at least 12 drug molecules per micelle compartment
in which the channel resides. Furthermore, remarkably selectiveFigure 6. Location of M2TM Sequence Variants and the Proposed Drug-Binding Sites
(A and B) The positions of residues mutated are shown in space-filling representation ([A], side; [B], pore) with the carbon atoms of each mutated residue in or-
ange, except for L38, which is shown in cyan for contrast. The remaining carbon atoms are shown in green.
(C) The position of rimantadine is inferred from the NMR study in pink near the bottom of the panel, versus the position of rimantadine (in orange) inferred from
crystallographic and mutagenesis studies. The geometric complementarity of the amantadine docked into the pore of the channel is striking.ts reserved
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detergents in a micelle are often observed (Fernandez et al.,
2002; Hilty et al., 2004), although they do not necessarily reflect
pharmacologically relevant binding events.
Finally, it is interesting to ask why the S31N mutation has only
recentlybecome dominant, even in areas where there is notselec-
tive pressure from drug use. This mutation had appeared many
times over the last decade, but until now it never showed a selec-
tive advantage in the absence of the drug. Thus, the dominance of
this lineage must arise from interactions with fitness-enhancing
mutations unrelated to drug resistance at other genomic sites
(Simonsenetal., 2007).A givenvariantofM2mustwork inconjunc-
tion with the viral hemagglutinin (HA) (Steinhauer et al., 1991),
which is responsible for the pH-dependent fusion of the viral
envelope with the endosomal membrane. When in the Golgi net-
work, the proton-channel activity of M2 is important for preventing
a premature conformational change of the HA of some subtypes
(Ciampor et al., 1992). Thus, the activity of the M2 must be suffi-
cient to ensure proper transit of HA to the cell surface, which
depends to a significant extent on the pH sensitivityof the HA mol-
ecules in the predominant strain of virus at a given time (Grambas
et al., 1992; Lamb et al., 1994; Pinto and Lamb, 2006).
We hypothesize that optimal proton flux and pH sensitivity of
M2 will drift with time in response to changes in the predominant
strain of HA. S31N is better matched to the requirements of the
HA proteins in the currently circulating viruses than the previous
wild-type with Ser31. Thus, this mutation might be seen to enjoy
multiple advantages including enhanced thermodynamic stabil-
ity, almost complete resistance to amantadine, and improved
functional matching to the requirements of the host and virus.
On the other hand, excessive channel activity might be deleteri-
ous to the host cell, which could contribute to the small-plaque
phenotype seen for L26F. Thus, the increased specific activity
Figure 7. The Effects of Mutations on the Free Energy of M2TM
Tetramer Dissociation
The change in free energy of tetramer dissociation upon mutation in micelles
(gray) and vesicles (black) is shown. L26F, S31N, I33A, and L38F mutations
stabilize tetramer formation in both environments, whereas H37A is destabiliz-
ing. Error bars represent the experimental errors listed in Table 1.Structure 16of this mutant together with its potential loss of conformational
specificity might contribute to its low frequency of occurrence
in the absence of a strong selective pressure from the presence
of amantadine.
EXPERIMENTAL PROCEDURES
Peptide Synthesis and Purification
N-terminally acetylated sequence variants of M2TM22–46 and M2TM19–46 pep-
tides (Figure 1) were synthesized using an Applied Biosystems 430A peptide
synthesizer on a 0.25 mmol scale, using Rink-amide resin with a 0.35 mmol/g
substitution level as in Stouffer et al. (2005). Fmoc-arginine-(Pbf)-OH and
Fmoc-glycine-OH were doubly coupled. A cocktail of TFA/thioanisole/1,2-
ethanedithiol/anisole (90:5:3:3, v/v) under nitrogen for 2 hr was used to cleave
the peptides from the resin and deprotect the amino acid side chains. Crude pep-
tide was precipitated and washed three times with ether/hexanes (50:50, v/v)
and dried under reduced pressure overnight. The peptide was then purified on
a semipreparative reverse-phase HPLC (Vydac C4 column) using a linear gra-
dient of buffer A (0.1% aqueous TFA) and buffer B (2-propanol/acetonitrile/
water, 6:3:1 containing 0.1% TFA) running from 60% to 100% buffer B. Elution
of pure peptide occurred at 82% buffer B. The purity of the peptides was
assessed on an analytical C4 column using a linear buffer A/B gradient, and
molecular weights were verified by MALDI-TOF (PerSeptive Biosystems)
mass spectrometry.
Site-Specific Mutagenesis, mRNA Synthesis,
Microinjection, and Culture of Oocytes
AM2L26F and AM2S31N, full-length protein from the Udorn strain of influenza A
virus, were prepared employing the QuikChange site-directed mutagenesis
method. Wild-type, AM2L26F, and AM2S31N cDNAs were linearized before
mRNA synthesis using their respective restriction sites. In vitro synthesis of
Figure 8. Correlation Plot of the Effect of Single-Site Mutations on
Free Energy of Tetramer Formation (DGtet) in Vesicles and the
Corresponding Effects in Micelles
Points that fall above the trend line indicate that mutations are more stabilizing
in vesicles, whereas points that fall below the line indicate that mutations are
more stabilizing in micelles. Error bars represent the experimental errors listed
in Table 1., 1067–1076, July 2008 ª2008 Elsevier Ltd All rights reserved 1073
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(Ambion). Ovarian lobules from femaleXenopus laeviswere removed by surgery
and treated with collagenase B (1 mg/ml; Roche Diagnostics) in Ca2+-free
OR-II solution (82.5 mM NaCl, 2 mM KCl, 1 mM MgCl2, 5 mM HEPES-NaOH
[pH 7.5]) at room temperature for 1–1.5 hr to free oocytes from follicle cells.
These oocytes were washed with OR-II a few times and maintained in ND96
solution (96 mM NaCl, 2 mM KCl, 1.8 mM CaCl2, 1 mM MgCl2, 2.5 mM sodium
pyruvate, 0.1 mg/ml gentamycin, 5 mM HEPES-NaOH [pH 8.5]). Oocytes of
good size, color, and shape were injected with 50 nl mRNA. The injected
oocytes were maintained in ND96 solution.
Equilibrium Analytical Ultracentrifugation
Centrifugation of M2TM22–46 S31N and H37A sequence variants was
performed and analyzed according to Stouffer et al. (2005).
Thiol-Disulfide Exchange Sample Preparation and Redox
Equilibration Reaction
M2TM19–46 peptide from a 2-propanol/water (1:1) stock was added to DLPC
from an ethanol stock. The peptide concentration was kept constant (20 mM)
and the peptide-to-detergent molar ratio was varied between samples from
1:50 to 1:2000. Stock solvents were evaporated under a stream of nitrogen
and the resultant films were left overnight under high vacuum. Sample vials
with air-tight caps were evacuated with argon gas. The film was then hydrated
with a degassed 100 mM Tris-HCl, 0.2 M KCl, 1 mM EDTA (pH 8.6) buffer
solution. This thiol-disulfide interchange reaction was initiated by adding oxi-
dized (GSSG) and reduced (GSH) glutathione so that their final concentrations
were 0.66 and 1.33 mM, respectively.
Samples were vigorously vortexed and sonicated until the peptide/deter-
gent film was completely incorporated into the glutathione-containing buffer.
Vesicles were equilibrated using the freeze-thaw method every 2 hr for 6 hr,
using a dry-ice acetone bath, followed by sonication until the samples became
clear (Cristian et al., 2003b). After equilibration, the reaction was quenched by
lowering the pH with HCl. The equilibrated samples were analyzed by reverse-
phase HPLC using an analytical C4 column with a linear buffer A/B gradient.
Eluant species consisted of DLPC, followed by a mixed disulfide of peptide
with GSH, the thiol-free monomer, and the disulfide-bonded peptide. The
latter three were identified by MALDI-TOF mass spectrometry. HPLC peaks
were integrated to determine the fraction of covalently bound dimer.
Data were fit to a function defined by the equilibria of Figure 2 using Igor Pro
(Wavemetrics) as described previously (Cristian et al., 2003b). Fitting variables
for WT were K1, K2, and a baseline correction required to account for irrevers-
ible aggregation. The WT value of K2 was used as a fixed parameter in fitting
the mutant data, with the reasoning that the similar structures and identical
buffer conditions should result in the same cysteine reactivities. Previously,
we found that a baseline correction was necessary to account for a fraction
of aggregated protein that was not in thermodynamic equilibrium. This value
showed no systematic trend between the mutants, and varied by approxi-
mately 10% (standard deviation of the difference from the mean).
Electrophysiological Recording
Whole-cell currents were recorded 48–72 hr after mRNA injection with a two-
electrode voltage-clamp apparatus consisting of a Dagan TEV 200A amplifier
(Axon Instruments) at room temperature using two electrodes filling with 3 mM
KCl. Individual oocytes were held at –20 mV and oocyte currents were mea-
sured at standard Barth’s solution (88 mM NaCl, 1.0 mM KCl, 2.4 mM NaHCO3,
0.3 mM NaNO3, 0.71 mM CaCl2, 0.82 mM MgSO4, 15 mM HEPES [pH 8.5]) or
15 mM MES (pH 5.5). Data were collected using pClamp10.0 software (Axon
Instruments, Molecular Devices). Amantadine hydrochloride (100 mM) was
dissolved in Barth’s solution (pH 5.5), and the final pH was checked and
adjusted to 5.5.
Immunofluorescence of Living Oocytes
Individual oocytes were fixed immediately after recording in ND96 solution
containing 2% formaldehyde in a 96-well plate for measurement of relative sur-
face expression levels. Oocytes were then incubated in ND96 solution with 2%
nonfat milk for 1 hr, for 30 min with 14C2 mouse monoclonal antibody (1:500
dilution, in ND96 solution with 2% milk), washed (33) with 2% milk containing
ND96 solution (10 min each), and finally incubated with goat anti-mouse IgG11074 Structure 16, 1067–1076, July 2008 ª2008 Elsevier Ltd All righ(g1) labeled with Alexa Fluor 546 (A21123, Molecular Probes; 40 mg/ml in 2%
milk containing ND96 solution) for 30 min. Free fluorophore was removed by
five more washes (10 min each) with ND96 solution. All steps were carried
out at 4C, and the ND96 solution used in this immunofluorescence study
lacked CaCl2, gentamycin, and pyruvate. Fluorescence was quantified using a
PTI image master microfluorometer (Photon Technologies) with a 20 3 0.5 NA
objective as described previously (Venkataraman et al., 2005). The brightest
part of each oocyte’s surface was imaged using a CCD camera when
exciting the Alexa Fluor with a 540 nm wavelength of light. Intensity quantifica-
tions were made using Image Master Version 5.0 software (Photon Technolo-
gies). Uninjected oocytes were subjected to the above conditions as a control
for the autofluorescence from the yolk (Beumer et al., 1995).
SUPPLEMENTAL DATA
Supplemental Data include one figure and can be found with this article online
at http://www.structure.org/cgi/content/full/16/7/1067/DC1/.
ACKNOWLEDGMENTS
A.L.S. thanks Kathleen Howard for providing resin containing M2TM
H37A22–46. This work was supported by NIH grants GM56423 (W.F.D.), AI-
31882 (L.H.P.), and AI-20201 (R.A.L.). R.A.L. is an investigator of the Howard
Hughes Medical Institute.
Received: November 14, 2007
Revised: March 24, 2008
Accepted: April 6, 2008
Published: July 8, 2008
REFERENCES
Abed, Y., Goyette, N., and Boivin, G. (2005). Generation and characterization
of recombinant influenza A (H1N1) viruses harboring amantadine resistance
mutations. Antimicrob. Agents Chemother. 49, 556–559.
Betakova, T., Ciampor, F., and Hay, A.J. (2005). Influence of residue 44 on the
activity of the M2 proton channel of influenza A virus. J. Gen. Virol. 86,
181–184.
Beumer, T.L., Veenstra, G.J., Hage, W.J., and Destree, O.H. (1995). Whole-
mount immunohistochemistry on Xenopus embryos using far-red fluorescent
dyes. Trends Genet. 11, 9.
Bowie, J.U. (2001). Stabilizing membrane proteins. Curr. Opin. Struct. Biol. 11,
397–402.
Bowie, J.U. (2004). Membrane proteins: a new method enters the fold. Proc.
Natl. Acad. Sci. USA 101, 3995–3996.
Bright, R.A., Medina, M.J., Xu, X.Y., Perez-Oronoz, G., Wallis, T.R., Davis,
X.H.M., Povinelli, L., Cox, N.J., and Klimov, A.I. (2005). Incidence of adaman-
tane resistance among influenza A (H3N2) viruses isolated worldwide from
1994 to 2005: a cause for concern. Lancet 366, 1175–1181.
Bright, R.A., Shay, D.K., Shu, B., Cox, N.J., and Klimov, A.I. (2006). Adaman-
tane resistance among influenza A viruses isolated early during the 2005–2006
influenza season in the United States. JAMA 295, 891–894.
Chen, H., Wu, Y., and Voth, G.A. (2007). Proton transport behavior through the
influenza A M2 channel: insights from molecular simulation. Biophys. J. 93,
3470–3479.
Chizhmakov, I.V., Geraghty, F.M., Ogden, D.C., Hayhurst, A., Antoniou, M.,
and Hay, A.J. (1996). Selective proton permeability and pH regulation of the
influenza virus M2 channel expressed in mouse erythroleukaemia cells.
J. Physiol. 494, 329–336.
Chizhmakov, I.V., Ogden, D.C., Geraghty, F.M., Hayhurst, A., Skinner, A., Be-
takova, T., and Hay, A.J. (2003). Differences in conductance of M2 proton
channels of two influenza viruses at low and high pH. J. Physiol. 546, 427–438.
Choma, C., Gratkowski, H., Lear, J.D., and DeGrado, W.F. (2000). Asparagine-
mediated self-association of a model transmembrane helix. Nat. Struct. Biol. 7,
161–166.ts reserved
Structure
Stability and Function of a Viral Proton ChannelCiampor, F., Thompson, C.A., Grambas, S., and Hay, A.J. (1992). Regulation of
pH by the M2 protein of influenza A viruses. Virus Res. 22, 247–258.
Cristian, L., Lear, J.D., and DeGrado, W.F. (2003a). Determination of mem-
brane protein stability via thermodynamic coupling of folding to thiol-disulfide
interchange. Protein Sci. 12, 1732–1740.
Cristian, L., Lear, J.D., and DeGrado, W.F. (2003b). Use of thiol-disulfide equi-
libria to measure the energetics of assembly of transmembrane helices in
phospholipid bilayers. Proc. Natl. Acad. Sci. USA 100, 14772–14777.
Czabotar, P.E., Martin, S.R., and Hay, A.J. (2004). Studies of structural
changes in the M2 proton channel of influenza A virus by tryptophan fluores-
cence. Virus Res. 99, 57–61.
Deyde, V.M., Xu, X., Bright, R.A., Shaw, M., Smith, C.B., Zhang, Y., Shu, Y.,
Gubareva, L.V., Cox, N.J., and Klimov, A.I. (2007). Surveillance of resistance
to adamantanes among influenza A(H3N2) and A(H1N1) viruses isolated
worldwide. J. Infect. Dis. 196, 249–257.
Fernandez, C., Hilty, C., Wider, G., and Wuthrich, K. (2002). Lipid-protein inter-
actions in DHPC micelles containing the integral membrane protein OmpX
investigated by NMR spectroscopy. Proc. Natl. Acad. Sci. USA 99,
13533–13537.
Fisher, L.E., Engelman, D.M., and Sturgis, J.N. (1999). Detergents modulate
dimerization, but not helicity, of the glycophorin A transmembrane domain.
J. Mol. Biol. 293, 639–651.
Fleming, K.G., and Engelman, D.M. (2001). Specificity in transmembrane helix-
helix interactions can define a hierarchy of stability for sequence variants.
Proc. Natl. Acad. Sci. USA 98, 14340–14344.
Fleming, K.G., Ackerman, A.L., and Engelman, D.M. (1997). The effect of point
mutations on the free energy of transmembrane a-helix dimerization. J. Mol.
Biol. 272, 266–275.
Fleming, K.G., Ren, C.C., Doura, A.K., Eisley, M.E., Kobus, F.J., and Stanley,
A.M. (2004). Thermodynamics of glycophorin A transmembrane helix dimer-
ization in C14 betaine micelles. Biophys. Chem. 108, 43–49.
Gandhi, C.S., Shuck, K., Lear, J.D., Dieckmann, G.R., DeGrado, W.F., Lamb,
R.A., and Pinto, L.H. (1999). Cu(II) inhibition of the proton translocation machin-
ery of the influenza A virus M2 protein. J. Biol. Chem. 274, 5474–5482.
Grambas, S., Bennett, M.S., and Hay, A.J. (1992). Influence of amantadine
resistance mutations on the pH regulatory function of the M2 protein of influ-
enza A viruses. Virology 191, 541–549.
Gratkowski, H., Lear, J.D., and DeGrado, W.F. (2001). Polar side chains drive
the association of model transmembrane peptides. Proc. Natl. Acad. Sci. USA
98, 880–885.
Hayden, F.G. (2006). Antiviral resistance in influenza viruses—implications for
management and pandemic response. N. Engl. J. Med. 354, 785–788.
Hilty, C., Wider, G., Fernandez, C., and Wuthrich, K. (2004). Membrane
protein-lipid interactions in mixed micelles studied by NMR spectroscopy
with the use of paramagnetic reagents. ChemBioChem 5, 467–473.
Holsinger, L.J., and Lamb, R.A. (1991). Influenza virus M2 integral membrane
protein is a homotetramer stabilized by formation of disulfide bonds. Virology
183, 32–43.
Holsinger, L.J., Nichani, D., Pinto, L.H., and Lamb, R.A. (1994). Influenza A
virus M2 ion channel protein: a structure-function analysis. J. Virol. 68,
1551–1563.
Howard, K.P., Lear, J.D., and DeGrado, W.F. (2002). Sequence determinants
of the energetics of folding of a transmembrane four-helix-bundle protein.
Proc. Natl. Acad. Sci. USA 99, 8568–8572.
Hu, J., Asbury, T., Achuthan, S., Li, C., Bertram, R., Quine, J.R., Fu, R., and
Cross, T.A. (2007). Backbone structure of the amantadine-blocked trans-
membrane domain M2 proton channel from influenza A virus. Biophys. J. 92,
4335–4343.
Kitahori, Y., Nakano, M., and Inoue, Y. (2006). Frequency of amantadine-resis-
tant influenza A virus isolated from 2001–02 to 2004–05 in Nara Prefecture.
Jpn. J. Infect. Dis. 59, 197–199.
Lamb, R.A., Holsinger, L.J., and Pinto, L.H. (1994). The influenza A virus M2 ion
channel protein and its role in the influenza virus life cycle. In Cellular Recep-Structure 16tors and Animal Viruses, E. Wimmer, ed. (Cold Spring Harbor, NY: Cold Spring
Harbor Laboratory Press), pp. 303–321.
Lear, J.D., Gratkowski, H., Adamian, L., Liang, J., and DeGrado, W.F. (2003).
Position-dependence of stabilizing polar interactions of asparagine in trans-
membrane helical bundles. Biochemistry 42, 6400–6407.
Lin, T.I., and Schroeder, C. (2001). Definitive assignment of proton selectivity
and attoampere unitary current to the M2 ion channel protein of influenza A
virus. J. Virol. 75, 3647–3656.
Lin, T.-I., Heider, H., and Schroeder, C. (1997). Different modes of inhibition by
adamantane amine derivatives and natural polyamines of the functionally
reconstituted influenza virus M2 proton channel protein. J. Gen. Virol. 78,
767–774.
Mould, J.A., Drury, J.E., Frings, S.M., Kaupp, U.B., Pekosz, A., Lamb, R.A.,
and Pinto, L.H. (2000). Permeation and activation of the M2 ion channel of
influenza A virus. J. Biol. Chem. 275, 31038–31050.
Nishimura, K., Kim, S., Zhang, L., and Cross, T.A. (2002). The closed state of
a H+ channel helical bundle combining precise orientational and distance
restraints from solid state NMR. Biochemistry 41, 13170–13177.
Okada, A., Miura, T., and Takeuchi, H. (2001). Protonation of histidine and
histidine-tryptophan interaction in the activation of the M2 ion channel from
influenza A virus. Biochemistry 40, 6053–6060.
Pinto, L.H., and Lamb, R.A. (2006). The M2 proton channels of influenza A and
B viruses. J. Biol. Chem. 281, 8997–9000.
Pinto, L.H., Dieckmann, G.R., Gandhi, C.S., Papworth, C.G., Braman, J.,
Shaughnessy, M.A., Lear, J.D., Lamb, R.A., and DeGrado, W.F. (1997). A func-
tionally defined model for the M2 proton channel of influenza A virus suggests
a mechanism for its ion selectivity. Proc. Natl. Acad. Sci. USA 94, 11301–
11306.
Russ, W.P., and Engelman, D.M. (1999). TOXCAT: a measure of transmem-
brane helix association in a biological membrane. Proc. Natl. Acad. Sci. USA
96, 863–868.
Russ, W.P., and Engelman, D.M. (2000). The GxxxG motif: a framework for
transmembrane helix-helix association. J. Mol. Biol. 296, 911–919.
Salom, D., Hill, B.R., Lear, J.D., and DeGrado, W.F. (2000). pH-dependent
tetramerization and amantadine binding of the transmembrane helix of M2
from the influenza A virus. Biochemistry 39, 14160–14170.
Schnell, J.R., and Chou, J.J. (2008). Structure and mechanism of the M2
proton channel of influenza A virus. Nature 451, 591–595.
Senes, A., Gerstein, M., and Engelman, D.M. (2000). Statistical analysis of
amino acid patterns in transmembrane helices: the GxxxG motif occurs
frequently and in association with b-branched residues at neighboring posi-
tions. J. Mol. Biol. 296, 921–936.
Senes, A., Engel, D.E., and DeGrado, W.F. (2004). Folding of helical membrane
proteins: the role of polar, GxxxG-like and proline motifs. Curr. Opin. Struct.
Biol. 14, 465–479.
Shimbo, K., Brassard, D.L., Lamb, R.A., and Pinto, L.H. (1996). Ion selectivity
and activation of the M2 ion channel of influenza virus. Biophys. J. 70, 1335–
1346.
Simonsen, L., Viboud, C., Grenfell, B.T., Dushoff, J., Jennings, L., Smit, M.,
Macken, C., Hata, M., Gog, J., Miller, M.A., et al. (2007). The genesis and
spread of reassortment human influenza A/H3N2 viruses conferring adaman-
tane resistance. Mol. Biol. Evol. 24, 1811–1820.
Steinhauer, D.A., Wharton, S.A., Skehel, J.J., Wiley, D.C., and Hay, A.J. (1991).
Amantadine selection of a mutant influenza virus containing an acid-stable
hemagglutinin glycoprotein: evidence for virus-specific regulation of the pH
of glycoprotein transport vesicles. Proc. Natl. Acad. Sci. USA 88, 11525–
11529.
Stouffer, A.L., Nanda, V., Lear, J.D., and DeGrado, W.F. (2005). Sequence
determinants of a transmembrane proton channel: an inverse relationship
between stability and function. J. Mol. Biol. 347, 169–179.
Stouffer, A.L., DeGrado, W.F., and Lear, J.D. (2006). Analytical ultracentrifuga-
tion studies of the influenza M2 homotetramerization equilibrium in detergent
solutions. Prog. Colloid Polym. Sci. 131, 108–115., 1067–1076, July 2008 ª2008 Elsevier Ltd All rights reserved 1075
Structure
Stability and Function of a Viral Proton ChannelStouffer, A.L., Acharya, R., Salom, D., Levine, A.S., Di Costanzo, L., Soto, C.S.,
Tereshko, V., Nanda, V., Stayrook, S., and DeGrado, W.F. (2008). Structural
basis for the function and inhibition of an influenza virus proton channel. Nature
451, 596–599.
Suzuki, H., Saito, R., Masuda, H., Oshitani, H., Sato, M., and Sato, I. (2003).
Emergence of amantadine-resistant influenza A viruses: epidemiological
study. J. Infect. Chemother. 9, 195–200.
Tamm, L.K., Hong, H., and Liang, B. (2004). Folding and assembly of b-barrel
membrane proteins. Biochim. Biophys. Acta 1666, 250–263.
Tang, Y., Zaitseva, F., Lamb, R.A., and Pinto, L.H. (2002). The gate of the influ-
enza virus M2 proton channel is formed by a single tryptophan residue. J. Biol.
Chem. 277, 39880–39886.1076 Structure 16, 1067–1076, July 2008 ª2008 Elsevier Ltd All righVenkataraman, P., Lamb, R.A., and Pinto, L.H. (2005). Chemical rescue of his-
tidine selectivity filter mutants of the M2 ion channel of influenza A virus. J. Biol.
Chem. 280, 21463–21472.
Wang, C., Takeuchi, K., Pinto, L.H., and Lamb, R.A. (1993). Ion channel activity
of influenza A virus M2 protein: characterization of the amantadine block.
J. Virol. 67, 5585–5594.
Wang, C., Lamb, R.A., and Pinto, L.H. (1995). Activation of the M2 ion channel
of influenza virus: a role for the transmembrane domain histidine residue.
Biophys. J. 69, 1363–1371.
Wu, Y., and Voth, G.A. (2005). A computational study of the closed and
open states of the influenza A M2 proton channel. Biophys. J. 89, 2402–
2411.ts reserved
